Stockreport

Immunomedics Announces Multiple Clinical and Preclinical Collaborations With Prominent Cancer Research Institutions

IMMUNOMEDICS  (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
PDF Clinical Collaboration with Yale University to Evaluate Sacituzumab Govitecan in Two Phase 2 Studies in Endometrial and Cervical Cancers Research Collaborations with Ya [Read more]